Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Public ClinicalTrials.gov record NCT00679588. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multinational, Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of AVE5026 With Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective is to compare the efficacy and safety of once daily (q.d.) subcutaneous (s.c.) injections of Semuloparin sodium (AVE5026) with q.d. s.c. injections of Enoxaparin for the prevention of Venous Thromboembolic Events (VTE) in patients undergoing major abdominal surgery. The secondary objectives are to evaluate the safety of Semuloparin sodium (AVE5026) and to document Semuloparin sodium (AVE5026) exposure in this population.
Study identification
- NCT ID
- NCT00679588
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 4,413 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2008 (Type not available)
- Primary completion
- Aug 2010 (Actual)
- Completion
- Aug 2010 (Actual)
- Last update posted
- Dec 16, 2013
2008 – 2010
United States locations
- U.S. sites
- 25
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational Site Number 840026 | Birmingham | Alabama | 35209 | — |
| Investigational Site Number 840035 | Birmingham | Alabama | 35209 | — |
| Investigational Site Number 840042 | Birmingham | Alabama | 35209 | — |
| Investigational Site Number 840002 | Birmingham | Alabama | 35234 | — |
| Investigational Site Number 840031 | Corlton | California | 82324 | — |
| Investigational Site Number 840007 | Huntingdon Beach | California | 92647 | — |
| Investigational Site Number 840014 | Los Angeles | California | 90033 | — |
| Investigational Site Number 840011 | Sant Barbara | California | 93105 | — |
| Investigational Site Number 840021 | Denver | Colorado | 80262 | — |
| Investigational Site Number 840029 | Clearwater | Florida | 33756 | — |
| Investigational Site Number 840017 | Jacksonville | Florida | 32209 | — |
| Investigational Site Number 840044 | Miami | Florida | 33136 | — |
| Investigational Site Number 840015 | Orlando | Florida | 32804 | — |
| Investigational Site Number 840009 | Columbus | Georgia | 31904 | — |
| Investigational Site Number 840019 | Maywood | Illinois | 60153 | — |
| Investigational Site Number 840036 | Springfield | Illinois | 62702 | — |
| Investigational Site Number 840037 | Hazard | Kentucky | 41701 | — |
| Investigational Site Number 840008 | St Louis | Missouri | 63104 | — |
| Investigational Site Number 840020 | Teaneck | New Jersey | 07666 | — |
| Investigational Site Number 840051 | Columbus | Ohio | 43210 | — |
| Investigational Site Number 840006 | Pittsburgh | Pennsylvania | 15240 | — |
| Investigational Site Number 840025 | Houston | Texas | 77024 | — |
| Investigational Site Number 840050 | Houston | Texas | 77070 | — |
| Investigational Site Number 840032 | Lubbock | Texas | 79409 | — |
| Investigational Site Number 840043 | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 245 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00679588, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2013 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00679588 live on ClinicalTrials.gov.